Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

US Patent 9193749 · Granted Nov 24, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds, pharmaceutical compositions, and methods of preparing compounds and o2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic mitochondrial activity inhibitors and uses thereof2025
Aryl-or heteroaryl-substituted benzene compounds2024
Aryl-OR heteroaryl-substituted benzene compounds2024
Aryl-or heteroaryl-substituted benzene compounds2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Carm1 inhibitors and uses thereof2023
Carm1 inhibitors and uses thereof2023
Heterocyclic mitochondrial activity inhibitors and uses thereof2023
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiet2023